Trials / Completed
CompletedNCT01327989
Solitaire FR Thrombectomy for Acute Revascularisation
STAR: Solitaire FR Thrombectomy for Acute Revascularisation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 202 (actual)
- Sponsor
- Medtronic Neurovascular Clinical Affairs · Industry
- Sex
- All
- Age
- 18 Years – 84 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study was to obtain prospective clinical data on the safety and efficacy of the Solitaire™ FR device for patients diagnosed with acute ischemic stroke.
Detailed description
The Study was a multi-center, single-arm, prospective, observational evaluation. The Solitaire™ FR Device has been certified for CE mark. This protocol evaluated the safety and efficacy of the Solitaire™ FR Device when used in routine practice and according to its Instructions for Use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Solitaire™ FR device | Mechanical Thrombectomy |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2012-10-01
- Completion
- 2013-01-01
- First posted
- 2011-04-04
- Last updated
- 2017-01-27
- Results posted
- 2017-01-27
Locations
2 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01327989. Inclusion in this directory is not an endorsement.